173 related articles for article (PubMed ID: 37937604)
41. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization.
Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J
Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194
[TBL] [Abstract][Full Text] [Related]
42. Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji.
Jiang R; Zhang JL; Satoh Y; Sairenji T
J Med Virol; 2004 Aug; 73(4):589-95. PubMed ID: 15221904
[TBL] [Abstract][Full Text] [Related]
43. The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases.
Zhang L; Wang R; Xie Z
Appl Microbiol Biotechnol; 2022 Jun; 106(12):4413-4426. PubMed ID: 35763069
[TBL] [Abstract][Full Text] [Related]
44. Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells.
Yajima M; Ikuta K; Kanda T
Viruses; 2018 Apr; 10(4):. PubMed ID: 29614006
[TBL] [Abstract][Full Text] [Related]
45. Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology.
Wang S; Xiong H; Yan S; Wu N; Lu Z
Sci Rep; 2016 May; 6():26156. PubMed ID: 27189712
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus strain characterization.
Munch M
APMIS; 1998 Apr; 106(4):425-33. PubMed ID: 9637263
[TBL] [Abstract][Full Text] [Related]
47. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
Takada K; Ji Z; Fujiwara S; Shimizu N; Tanabe-Tochikura A
J Virol; 1992 Sep; 66(9):5590-3. PubMed ID: 1323712
[TBL] [Abstract][Full Text] [Related]
48. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8.
Ba Abdullah MM; Palermo RD; Palser AL; Grayson NE; Kellam P; Correia S; Szymula A; White RE
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904201
[TBL] [Abstract][Full Text] [Related]
49. The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.
Kanai K; Satoh Y; Yamanaka H; Kawaguchi A; Horie K; Sugata K; Hoshikawa Y; Sata T; Sairenji T
Virus Genes; 2007 Dec; 35(3):563-9. PubMed ID: 17763933
[TBL] [Abstract][Full Text] [Related]
50. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
51. Accurate reconstruction of viral genomes in human cells from short reads using iterative refinement.
Lee SD; Wu M; Lo KW; Yip KY
BMC Genomics; 2022 Jun; 23(1):422. PubMed ID: 35668367
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.
Renzette N; Somasundaran M; Brewster F; Coderre J; Weiss ER; McManus M; Greenough T; Tabak B; Garber M; Kowalik TF; Luzuriaga K
J Virol; 2014 Apr; 88(7):3744-55. PubMed ID: 24429365
[TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of 22 Epstein-Barr virus genomes from diseased and healthy individuals.
Zhou L; Chen JN; Qiu XM; Pan YH; Zhang ZG; Shao CK
J Gen Virol; 2017 Jan; 98(1):96-107. PubMed ID: 28036243
[TBL] [Abstract][Full Text] [Related]
54. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
[TBL] [Abstract][Full Text] [Related]
55. Geographic Population Structure in Epstein-Barr Virus Revealed by Comparative Genomics.
Chiara M; Manzari C; Lionetti C; Mechelli R; Anastasiadou E; Chiara Buscarinu M; Ristori G; Salvetti M; Picardi E; D'Erchia AM; Pesole G; Horner DS
Genome Biol Evol; 2016 Dec; 8(11):3284-3291. PubMed ID: 27635051
[TBL] [Abstract][Full Text] [Related]
56. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
57. Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil.
Klumb CE; Hassan R; De Oliveira DE; De Resende LM; Carriço MK; De Almeida Dobbin J; Pombo-De-Oliveira MS; Bacchi CE; Maia RC
Int J Cancer; 2004 Jan; 108(1):66-70. PubMed ID: 14618617
[TBL] [Abstract][Full Text] [Related]
58. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
[TBL] [Abstract][Full Text] [Related]
59. [Epstein-Barr virus (
Yakushina SA; Kisteneva LB
Vopr Virusol; 2020 Sep; 65(4):191-202. PubMed ID: 33533222
[TBL] [Abstract][Full Text] [Related]
60. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
